Exchange Rate
This document contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this document were made at a rate of EUR 1.00 to USD 1.1884, the reference rate of the European Central Bank on June 30, 2021.
Conference Call and Webcast
Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the second quarter of 2021 on Thursday, July 29, 2021, at 8:30 a.m. ET/2:30 p.m. CET. Company participants on the call will include Wilfried Vancraen, Founder and Chief Executive Officer; Peter Leys, Executive Chairman; and Johan Albrecht, Chief Financial Officer. A question-and-answer session will follow management’s remarks.
- To access the conference call, please dial 844-469-2530 (U.S.) or 765-507-2679 (international), passcode 3659266#.
The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company’s website at http://investors.materialise.com. A webcast of the conference call will be archived on the company's website for one year.
About Materialise
Materialise incorporates 30 years of 3D printing experience into a range of software solutions and 3D printing services, which form the backbone of the 3D printing industry. Materialise’s open and flexible solutions enable players in a wide variety of industries, including healthcare, automotive, aerospace, art and design, and consumer goods, to build innovative 3D printing applications that aim to make the world a better and healthier place. Headquartered in Belgium, with branches worldwide, Materialise combines one of the largest groups of software developers in the industry with one of the largest 3D printing facilities in the world. For additional information, please visit: www.materialise.com.
Cautionary Statement on Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our current estimates for fiscal 2021 revenues and Adjusted EBITDA, results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the COVID-19 pandemic and related public health measures, as well as the related actions we are taking in response), and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words “estimate,” “expect,” “anticipate,” “project,” “plan,” “intend,” “believe,” “forecast,” “will,” “may,” “could,” “might,” “aim,” “should,” and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's most recent actual results to differ materially from our expectations, including risk factors described in the company's most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this press release. For example, the variant strains of the COVID-19 virus could have a material adverse impact on the global economic recovery from the pandemic.
The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.
Consolidated income statements (Unaudited)
for the three months ended
June 30, |
for the six months ended
June 30, |
|||||||||
In 000€ | 2021 |
|
2021 |
|
2020 (*) |
|
2021 |
|
2020 (*) |
|
U.S.$ | € | € | € | € | ||||||
Revenue | 60,267 |
50,713 |
38,117 |
96,266 |
84,362 |
|||||
Cost of Sales | (26,468) |
(22,272) |
(18,168) |
(43,258) |
(39,827) |
|||||
Gross Profit | 33,799 |
28,441 |
19,949 |
53,009 |
44,535 |
|||||
Gross profit as % of revenue | 56.1% |
56.1% |
52.3% |
55.1% |
52.8% |
|||||
Research and development expenses | (8,133) |
(6,844) |
(6,045) |
(13,380) |
(12,572) |
|||||
Sales and marketing expenses | (14,269) |
(12,007) |
(10,161) |
(23,317) |
(22,789) |
|||||
General and administrative expenses | (9,521) |
(8,012) |
(6,499) |
(15,565) |
(13,696) |
|||||
Net other operating income (expenses) | 1,002 |
843 |
892 |
1,963 |
1,575 |
|||||
Operating (loss) profit | 2,878 |
2,421 |
(1,865) |
2,710 |
(2,948) |
|||||
Financial expenses | (969) |
(815) |
(640) |
(5,515) |
(2,461) |
|||||
Financial income | 2,339 |
1,968 |
345 |
2,556 |
845 |
|||||
Share in loss of joint venture | - |
- |
- |
- |
(39) |
|||||
(Loss) profit before taxes | 4,248 |
3,574 |
(2,160) |
(249) |
(4,603) |
|||||
Income Taxes | (156) |
(131) |
191 |
25 |
(267) |
|||||
Net (loss) profit for the period | 4,092 |
3,443 |
(1,969) |
(224) |
(4,870) |
|||||
Net (loss) profit attributable to: | - |
|||||||||
The owners of the parent | 4,092 |
3,443 |
(1,902) |
(224) |
(4,743) |
|||||
Non-controlling interest | - |
- |
(67) |
- |
(127) |
|||||
Earning per share attributable to owners of the parent | ||||||||||
Basic | 0.07 |
0.06 |
(0.04) |
(0.00) |
(0.09) |
|||||
Diluted | 0.07 |
0.06 |
(0.04) |
(0.00) |
(0.09) |
|||||
Weighted average basic shares outstanding | 54,873 |
54,873 |
53,194 |
54,521 |
53,194 |
|||||
Weighted average diluted shares outstanding | 55,115 |
55,115 |
53,194 |
54,521 |
53,194 |
(*) |
The year 2020 has been restated to reflect the final accounting of the business combination with Engimplan. |
|
Impact on the year to date operating result of the (83) kEUR |